Literature DB >> 7178844

Thought disorder or speech disorder in schizophrenia?

E Chaika.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 7178844     DOI: 10.1093/schbul/8.4.587

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  8 in total

Review 1.  The Epidemiology and Associated Phenomenology of Formal Thought Disorder: A Systematic Review.

Authors:  Eric Roche; Lisa Creed; Donagh MacMahon; Daria Brennan; Mary Clarke
Journal:  Schizophr Bull       Date:  2014-09-01       Impact factor: 9.306

Review 2.  Bilingualism and schizophrenia.

Authors:  Mary V Seeman
Journal:  World J Psychiatry       Date:  2016-06-22

3.  Talk about talk: metacommentary and context in the analysis of psychotic discourse.

Authors:  S Swartz; L Swartz
Journal:  Cult Med Psychiatry       Date:  1987-12

Review 4.  Issues in the analysis of psychotic speech.

Authors:  S Swartz
Journal:  J Psycholinguist Res       Date:  1994-01

5.  Language content and schizophrenia in acute phase Turkish patients.

Authors:  L Mete; P P Schnurr; S D Rosenberg; T E Oxman; I Doganer; S Sorias
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1993-11       Impact factor: 4.328

6.  Inner Speech and Clarity of Self-Concept in Thought Disorder and Auditory-Verbal Hallucinations.

Authors:  Paulo de Sousa; William Sellwood; Amy Spray; Charles Fernyhough; Richard P Bentall
Journal:  J Nerv Ment Dis       Date:  2016-12       Impact factor: 2.254

7.  The Bayesian brain and cooperative communication in schizophrenia.

Authors:  Lena Palaniyappan; Ganesan Venkatasubramanian
Journal:  J Psychiatry Neurosci       Date:  2022-02-08       Impact factor: 6.186

8.  Resting state perfusion in the language network is linked to formal thought disorder and poor functional outcome in schizophrenia.

Authors:  K Stegmayer; M Stettler; W Strik; A Federspiel; R Wiest; S Bohlhalter; S Walther
Journal:  Acta Psychiatr Scand       Date:  2017-09-02       Impact factor: 6.392

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.